HOME >> MEDICINE >> NEWS
Antibiotics help heart patients

DALLAS, Aug. 20 In the largest study of its kind published to date, researchers report that hospitalized heart patients who took antibiotics had a significantly lower risk of returning to the hospital with severe chest pain within one year compared with those on a placebo.

The study suggests that antiobiotics might have an anti-inflammatory benefit. The study appears in today's rapid access issue of Circulation: Journal of the American Heart Association.

Researchers were surprised to find that the reduced risk was not related to the presence of two bacteria suspected of playing a role in heart disease Helicobacter pylori and Chlamydia pneumoniae.

"The beneficial effect of the antibiotics was independent of whether a person was infected with H. pylori or C. pneumonia," says author Michael A. Mendall, M.D., a consultant gastroenterologist at the Mayday Hospital in Croydon, England. "This implies these antibiotics are not working against these organisms. The antibiotics may be acting against other organisms to reduce the overall infectious burden of the body or may have their own anti-inflammatory properties."

The study is the first to compare two different classes of antibiotics in treating acute coronary syndromes. Researchers enrolled 325 patients (225 men and 100 women, ages 39 to 80) hospitalized with a heart attack or unstable angina (severe, unexpected chest pain that occurs at rest). Within 48 hours after being admitted, the patients were randomized to receive amoxycillin, azithromycin, or a placebo for one week. Those in the antibiotic groups also received omeprazole and metronidazole, drugs used in combination with the antibiotics to eradicate H. pylori.

At the start of the study, tests revealed that 157 of 310 patients (51 percent) had antibodies to H. pylori and 132 of 325 patients (41 percent) had antibodies to C. pneumoniae. Blood tests for antibodies detect the dormant bacteria. C. pneumoniae causes
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
19-Aug-2002


Page: 1 2 3

Related medicine news :

1. Antibiotics protect nerves in mice by turning on genes
2. Antibiotics within 4 hours of arrival at hospital better for pneumonia patients
3. Antibiotics not always beneficial for childhood ear infections
4. Antibiotics Reduce Inflammation In Heart Disease But Effect On Heart Attacks Remains Unproven
5. Understanding Why Antibiotics May Be Over-prescribed For Patients With Sore Throats
6. Researchers Synthesize Compounds For New Class Of Antibiotics
7. New study in Nature demonstrates protection against cell death during heart attack
8. Uric acid and heart disease
9. Researchers search for first sign of congestive heart failure
10. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
11. Extreme exertion, emotion can spark repeat heart attacks

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Antibiotics help heart patients

(Date:9/2/2015)... ... , ... Every year at this time, students prepare to go back to ... face the academic workload confronting them. They just don’t have the skills needed to ... teach students how to study. , “Bankers bank. Salesmen sell. Teachers teach. The job ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... announces Hand Free Pocket Cop, a safety invention that protects people from crime ... worth $31 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:9/2/2015)... ... , ... Ovarian cancer continues to be the deadliest of all gynecologic cancers. ... her lifetime is approximately 1 in 75. This year it is estimated that approximately ... , There is no test to detect ovarian cancer. A Pap test does ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich Cream ... cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for intense ...
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy Partners, a North Carolina ... Inc. 5000 List, an independent ranking of the fastest- growing private companies ... this achievement puts Canopy in rarefied company. Over the years, this elite group ...
Breaking Medicine News(10 mins):Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2
(Date:9/2/2015)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and ... into a definitive agreement under which Valeant will acquire ... SURG ) for $6.50 per share in cash. In ... receive additional cash payments of up to $1.00 per ... closing.  The transaction is expected to close in the ...
(Date:9/2/2015)... 2015 Tumultuous market conditions – including changes ... M&A activity – have led more than half of ... sales reps. This marks the first time that the ... halfway point, according to the spring 2015 AccessMonitor™ ... ZS . AccessMonitor™ aggregates sales-call ...
(Date:9/2/2015)... JUNCTION, N.J. , Sept. 2, 2015 ... immunotherapy leader commercializing its CytoSorb ® blood purification ... around the world, announced that CEO Dr. Phillip ... & Renshaw Annual Global Investment Conference (sponsored by ... 8-10 th in New York City.  ...
Breaking Medicine Technology:Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 2CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 3CytoSorbents to Present at the 2015 Rodman & Renshaw Annual Global Investment Conference 4
Cached News: